Abstract
Iron chelation therapy is the main treatment for iron overload disease. Iron chelators were recently reported to be useful for cancer therapy; however, they cause side effects that make them difficult to use in some cancer patients. Thus, a novel oral iron chelator, super-polyphenol (SP), was developed for cancer therapy to decrease the side effects. SP is either water soluble or insoluble, and has different isoforms according to the number of side chains. Of these isoforms, water-soluble SP6 and SP10 appear to be the best candidates, as they have the strongest chelating abilities. In this study, we focused on the usefulness and safety of SP6 and SP10 as anti-cancer drugs, and examined their anti-cancer effects and toxicity. The results showed that SP6 and SP10 inhibited cancer cell proliferation by inducing apoptosis in HCT116, HSC-2, A549, and MCF-7 cancer cells. SP10 also inhibited tumor growth in an HCT116 xenograft model. SP6 and SP10 had no acute toxicities. An intravenous injection test revealed that SP6 and SP10 had better safety profiles than the iron chelator deferoxamine. In conclusion, SP is a novel oral iron chelator with anti-cancer effects and few adverse side effects. This is the first report of SP in the litera...Continue Reading
References
Nov 1, 1989·British Journal of Cancer·S OkadaO Midorikawa
Aug 1, 1996·Nature Genetics·J N FederR K Wolff
Jun 5, 1997·Biochimica Et Biophysica Acta·T TanakaK Tanaka
May 23, 1998·The Journal of Biological Chemistry·R U JänickeA G Porter
Jan 20, 2007·British Journal of Haematology·Elliott VichinskyUNKNOWN Deferasirox in Sickle Cell Investigators
Sep 15, 2007·Critical Care Medicine·Michael A TortoriciSamuel M Poloyac
Nov 21, 2008·Cancer Science·Shinya Toyokuni
Dec 17, 2008·Blood Reviews·John C Wood
Apr 17, 2009·The American Journal of Clinical Nutrition·Natasa TasevskaAmanda J Cross
Jun 11, 2009·British Journal of Cancer·L M FerrucciR Sinha
Oct 8, 2009·American Journal of Epidemiology·Rashmi SinhaAmanda J Cross
Jun 23, 2010·Blood·Jong Wook LeeUNKNOWN EPIC study investigators
Jun 2, 2011·Blood·M Domenica CappelliniYesim Aydinok
Aug 13, 2011·The New England Journal of Medicine·Takahiro YamasakiIsao Sakaida
Oct 18, 2012·Molecular Pharmacology·Goldie Y L LuiDes R Richardson
Nov 7, 2012·British Journal of Pharmacology·S J FordC Tselepis
Nov 20, 2012·International Journal of Cancer. Journal International Du Cancer·Toshiaki OharaToshiyoshi Fujiwara
Apr 19, 2016·Cancer Biology & Therapy·Shinichi UranoToshiyoshi Fujiwara
Apr 20, 2016·Arhiv za higijenu rada i toksikologiju·Valon KrasniqiNada Božina
Sep 3, 2016·International Journal of Molecular Sciences·Jehn-Chuan LeeHorng-Heng Juang
Oct 16, 2016·Oncotarget·Abou DialloMathilde Touvier
Nov 12, 2016·World Journal of Gastroenterology : WJG·Issei SaekiIsao Sakaida
Mar 16, 2017·Pediatric Blood & Cancer·Elliott VichinskyMohsen Elalfy
Dec 13, 2017·Oncotarget·Takayuki NinomiyaToshiyoshi Fujiwara
Dec 17, 2017·Scientific Reports·Chiara RaggiStefania Recalcati
Citations
Nov 6, 2018·Journal of Magnetic Resonance Imaging : JMRI·Zhang Li-OuGuo Qi-Yong
Oct 19, 2019·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Anna L GreenshieldsDavid W Hoskin
May 21, 2020·Nanomedicine·Gregory JonesJonghan Kim
Jun 27, 2020·Cells·Marco FiorilloMichael P Lisanti
Mar 5, 2021·International Journal of Cancer. Journal International Du Cancer·Toru NarusakaToshiyoshi Fujiwara